| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $773K | -3.1% |
| SG&A Expense | $1.7M | +5.3% |
| Operating Income | -$2.5M | -2.6% |
| Pre-tax Income | -$3.3M | +19.4% |
| Net Income | -$3.3M | +19.4% |
| EPS (Basic) | -$2.51 | +33.4% |
| EPS (Diluted) | -$2.51 | +33.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12K | +3.9% |
| Inventory | $50K | +0.0% |
| Current Assets | $21K | -82.0% |
| Total Assets | $214K | -33.6% |
| Current Liabilities | $4.6M | +27.9% |
| Long-term Debt | $2.0M | -19.4% |
| Total Liabilities | $4.7M | +25.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$872K | +36.9% |
| Financing Cash Flow | $873K | -37.0% |
| Stockholders' Equity |
| -$4.5M |
| -30.6% |